Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 3.61% to $1.33 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.94% to 12,338.95 and Dow Jones Industrial Average DJIA falling 0.35% to 30,068.81. Corbus Pharmaceuticals Holdings Inc. closed $8.45 short of its 52-week high ($9.78), which the company reached on August 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Fate Therapeutics Inc. FATE fell 5.46% to $86.60, Vanda Pharmaceuticals Inc. VNDA fell 1.98% to $13.38, and Viking Therapeutics Inc. VKTX fell 4.24% to $5.98. Trading volume (3.6 M) remained 958,242 below its 50-day average volume of 4.6 M.